Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI ....
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Ltd has informed the stock exchanges that its Board of Directors will meet on Monday, 3rd November 2025. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2025 (Q2 FY26 and H1 FY26). The trading window for dealing in the company's shares, which was already closed from 1st October 2025, will remain shut until 48 hours after the results are declared on 3rd November. The intimation has been made under Regulation 29(1) of SEBI's Listing Obligations and Disclosure Requirements.
This is a routine pre-results announcement and signals that the company's Q2 FY26 earnings will be declared on 3rd November 2025. Investors should watch the results announcement date for actual financial performance; no material impact on the stock is expected from this notice alone.